Tamoxifen is a nonsteroidal synthetic selective estrogen receptor modulator (SERM) that inhibits estrogen receptor (ER) activity in the breast and is a widely used therapeutic agent for BC patients with ER-positive tumors (79). The gene discussed is ESR1; the disease is breast cancer.